FDA approves twice-yearly injection that prevents HIV, thanks in part to research by a Spokane doctor


A few weeks ago, Grant Ogren and Rhea Ashby-Durall, the executive director and the outreach manager of SAN (formerly Spokane AIDS Network), met with their representative from Gilead Sciences, the pharmaceutical company known for its antiviral drugs that treat and prevent HIV and AIDS…